Real frequency of ordinary and atypical sub-trochanteric and diaphyseal fractures in France based on X-rays and medical file analysis

Joint Bone Spine

Volumn 80, Issue 2, 2013, Pages 201-205

  Beaudouin Bazire, Constance ^a   Dalmas, Noémie ^b   Bourgeois, Julie ^c   Babinet, Antoine ^d   Anract, Philippe ^d   Chantelot, Christophe ^e   Farizon, Frédéric ^c   Chopin, Florence ^c   Briot, Karine ^a   Roux, Christian ^a   Cortet, Bernard ^b   Thomas, Thierry ^c  

^a Institut Cochin   (France)

^b UNIV LILLE   (France)

^c UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Atypical fracture; Automated data; Femoral shaft fracture; Sub trochanteric fracture

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; IBANDRONIC ACID; RISEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE RADIOGRAPHY; CLINICAL STUDY; FEMALE; FEMUR NECK FRACTURE; FEMUR SHAFT FRACTURE; FEMUR SUBTROCHANTERIC FRACTURE; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; X RAY ANALYSIS;

AGED; AGED, 80 AND OVER; BONE DISEASES; DIAPHYSES; DOCUMENTATION; FEMALE; FEMORAL FRACTURES; FEMUR; FRACTURES, SPONTANEOUS; FRANCE; HIP FRACTURES; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; MALE; MEDICAL RECORDS; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84875511805     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2012.07.012     Document Type: Article

References (32)

1. Nieves J.W., Bilezikian J.P., Lane J.M., et al. Fragility fractures of the hip and femur: incidence and patient characteristics. Osteoporos Int 2010, 21:299-408.
2. Salminen S., Pihlajamäki H., Avikainen V., et al. Specific features associated with femoral shaft fractures caused by low-energy trauma. J Trauma 1997, 43:117-122.
3. Abrahamsen B., Eiken P., Eastell R. Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res 2009, 24:1095-1102.
4. Giusti A., Hamdy N.A., Dekkers O.M., et al. Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features. Bone. 2011, 48:966-971.
5. Weiss R.J., Montgomery S.M., Al Dabbagh Z., et al. National data of 6409 Swedish inpatients with femoral shaft fractures: stable incidence between 1998 and 2004. Injury 2009, 40:304-308.
6. Adachi J., Lyles K., Boonen S., et al. Subtrochanteric fractures in bisphosphonate-naïve patients: results from the HORIZON-recurrent fracture trial. Calcif Tissue Int 2011, 89:427-433.
7. Kannus P., Palvanen M., Niemi S., et al. Epidemiology of osteoporotic pelvic fractures in elderly people in Finland: sharp increase in 1970-1997 and alarming projections for the new millennium. Osteoporos Int 2000, 11:443-448.
8. Kannus P., Palvanen M., Parkkari J., et al. Osteoporotic pelvic fractures in elderly women. Osteoporos Int 2005, 16:1304-1305.
9. Wang Z., Bhattacharyya T. Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996-2007. J Bone Miner Res 2011, 26:553-560.
10. Maravic M., Ostertag A., Cohen-Solal M. Subtrochanteric/femoral shaft versus hip fractures: Incidences and identification of risk factors. J Bone Miner Res 2011.
11. Schilcher J., Michaëlsson K., Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 2011, 364:1728-1737.
12. Shane E., Burr D., Ebeling P.R., et al. American Society for Bone and Mineral Research. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2010, 25:2267-2294.
13. Audran M., Cortet B., Thomas T. Bone division of the French Society for Rheumatology. What do we know about atypical femoral fractures? Insights and enigmas. Joint Bone Spine 2011, 78:568-571.
14. Neviaser A.S., Lane J.M., Lenart B.A., et al. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 2008, 22:346-350.
15. Lenart B.A., Neviaser A.S., Lyman S., et al. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int 2009, 20:1353-1362.
16. Lenart B.A., Lorich D.G., Lane J.M. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 2008, 358:1304-1306.
17. Abrahamsen B., Eiken P., Eastell R. Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis. J Clin Endocrinol Metab 2010, 95:5258-5265.
18. Vestergaard P., Schwartz F., Rejnmark L., et al. Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene. Osteoporos Int 2011, 22:993-1001.
19. Kim S.Y., Schneeweiss S., Katz J.N., et al. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort. J Bone Miner Res 2011, 26:993-1001.
20. Park-Wyllie L.Y., Mamdani M.M., Juurlink D.N., et al. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 2011, 305:783-789.
21. Black D.M., Kelly M.P., Genant H.K., et al. Biphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med 2010, 362:1761-1771.
22. Girgis C.M., Sher D., Seibel M.J. Atypical femoral fractures and bisphosphonate use. N Engl J Med 2010, 362:1848-1849.
23. Ray W.A., Griffin M.R., Fought R.L., et al. Identification of fractures from computerized Medicare files. J Clin Epidemiol 1992, 45:703-714.
24. Spangler L., Ott S.M., Scholes D. Utility of automated data in identifying femoral shaft and subtrochanteric (diaphyseal) fractures. Osteoporos Int 2011, 22:2523-2527.
25. Giusti A., Hamdy N., Papapoulos S. Atypical fractures of the femur and bisphosphonate therapy, a systematic review of case/case series studies. Bone 2010, 47:169-180.
26. Evans J.G. Fractured proximal femur in Newcastle upon Tyne. Age ageing 1979, 8:16-24.
27. Fisher E.S., Whaley F.S., Krushat W.M., et al. The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Health 1992, 82:243-248.
28. Huang S.Y., Grimsrud C.D., Provus J., et al. The impact of subtrochanteric fracture criteria on hip fracture classification. Osteoporos Int 2012, 23:743-750.
29. Meary R. Code de classement des affections, interventions et références bibliographiques intéressant l'orthopédie et la traumatologie. Rev Chir Orthop 1966, 52:125-136.
30. Compston J. Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw. Osteoporos Int 2011, 22:2951-2961.
31. Kilcoyne A., Heffernan E.J. Atypical proximal femoral fractures in patients with Paget disease receiving bisphosphonate therapy. Am J Roentgenol 2011, 197:196-197.
32. Puhaindran M.E., Farooki A., Steensma M.R., et al. Atypical subtrochanteric femoral fractures in patients with skeletal malignant involvement treated with intravenous bisphosphonates. J Bone Joint Surg Am 2011, 93:1235-1242.